The knowledge base

During the International LAMA2 Conference in Istanbul, a live stream with live translation of the presentations will be available on…

The Prinses Beatrix Spierfonds, Stichting Voor Sara, CureCMD and Giving Strength are continuing their collaboration with Radboudumc by extending and…

Modalis Therapeutics, the biotechnology company developing novel gene-based therapies for the rare inherited muscle disease LAMA2-MD, has recently published an…

The Dutch foundation Voor Sara is investing over €45,000 in a promising research project led by Professor Markus Rüegg at…

The French patient association LAMA2 France, dedicated to people affected by LAMA2-related dystrophy (LAMA2-RD), is pleased to announce that they…

Postdoctoral researcher Boris Shneyer shares the latest developments in his research on LAMA2-RD, the progress made so far, and the…